A study on cord blood stem cells and platelet-rich plasma for treating pregnancy stretch marks

The effect of autologous umbilical cord blood stem cells and platelet-rich plasma on striae gravidarum

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN17235665

Enrollment

Registered

2021-11-09

Start date

2021-11-15

Completion date

Unknown

Last updated

2021-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Striae gravidarum Skin and Connective Tissue Diseases

Interventions

Control group: left abdomen of each participant, no treatment. Intervention group: right abdomen of each participant, PRP stem cell transplantation. Transplantation: 1

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 1. Pregnant women with striae gravidarum 2. Full-term or cesarean delivery 3. Aged 23 to 30 years

Exclusion criteria

Exclusion criteria: 1. Participant in other ongoing clinical trials 2. Tested positive for hepatitis B, hepatitis C, HIV, syphilis, EBV, or CMV 3. History of severe allergic reactions or adverse reactions to medication

Design outcomes

Primary

Measure	Time frame
Visual changes measured using abdomen photos at baseline, the 7th day after each transplantation (i.e., day 8, 17, and 27 post-delivery), month 2, and month 3 post-delivery	—

Secondary

Measure	Time frame
Measured at baseline, day 8, 17, 27, month 2, and month 3 post-delivery: 1. Pain caused by striae gravidarum measured using self-reporting questionnaires 2. Pruritus caused by striae gravidarum measured using self-reporting questionnaires	—

Countries

China

Contacts

Public ContactYutong Ge

yutong@sycellcenter.com+86 (0)24 15142525031

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026